FindTrial
Sign In

The effect of Spray lidocaine on the blade of laryngoscope on cardiovascular responses

Comparison of the effect of 10% lidocaine spray on blade of laryngoscope with IV lidocaine on the cardiovascular responses to laryngoscopy and endotracheal intubation in patients with elective surgery

Status
Active, not recruiting
Phases
Phase 3
Study type
Interventional
Source
IRCT
Registry ID
IRCT2013061213647N1
Enrollment
90
Registered
2014-03-11
Start date
2013-12-31
Completion date
Unknown
Last updated
2018-02-22

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Associated with 10% lidocaine spray on the blade of laryngoscope and intravenous lidocaine on cardiovascular responses.

Interventions

Intervention 1: The patients placed in 3 groups. The three groups are given same doses of anesthetics(Propofol 2 mg/kg, Atracurium 0/4 mg/kg and Fentanyl 2 mic/kg).Intravenous lidocaine in Group IV 1
Prevention
The patients placed in 3 groups. The three groups are given same doses of anesthetics(Propofol 2 mg/kg, Atracurium 0/4 mg/kg and Fentanyl 2 mic/kg).Intravenous lidocaine in Group IV 1 mg/kg 60-90 se
The patients placed in 3 groups. The three groups are given same doses of anesthetics(Propofol 2 mg/kg, Atracurium 0/4 mg/kg and Fentanyl 2 mic/kg) and in spray group 10% lidocaine spray 1/5 mg/kg t
The patients placed in 3 groups. The three groups are given same doses of anesthetics(Propofol 2 mg/kg? Atracurium 0/4 mg/kg and Fentanyl 2 mic/kg) and in control group did not use any drug.Their bl

Sponsors

Vice Chancellor for Research of Gonabad University of Medical Science
Lead Sponsor

Eligibility

Sex/Gender
All
Age
15 Years to 65 Years

Inclusion criteria

Inclusion criteria: Inclusion criteria: Age range 15-65 years; Patients with anesthesia class 1; Patients with Mallampati airway class 1; Patients are willing to participate in the study Exclusion criteria: More than once in an effort to laryngoscopy and intubation; ?Allergy to lidocaine; Weight more than 100 kg

Exclusion criteria

Exclusion criteria:

Design outcomes

Primary

MeasureTime frame
Systolic Blood Pressure. Timepoint: Immediately before intrvention, Immediately after intervention and 1, 3, 5 minute after intervention. Method of measurement: Mmhg with Sphygmomenometer.;Heart rate. Timepoint: Immediately before intrvention, Immediately after intervention and 1, 3, 5 minute after intervention. Method of measurement: Beat per minute with pulseoximetery.;Dyastolic Blood Pressure. Timepoint: Immediately before intrvention, Immediately after intervention and 1, 3, 5 minute after intervention. Method of measurement: Mmhg with Sphygmomenometer.;Mean Arterial Blood pressure. Timepoint: Immediately before intrvention, Immediately after intervention and 1, 3, 5 minute after intervention. Method of measurement: Mmhg with Sphygmomenometer.—

Countries

Iran (Islamic Republic of)

Contacts

Public ContactMahdi Esmaeili

Gonabad University of Medical Science

Esmaeili.Mahdi@gmu.ac.ir; Mahdi.Esmaeili@yahoo.com+98 53 3722 5027

Outcome results

None listed

Source: IRCT (via WHO ICTRP) · Data processed: Feb 4, 2026